8-K 2013 ANNUAL MEETING VOTE


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________
FORM 8-K
_______________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 23, 2013 (May 22, 2013)

_______________________________
ENDO HEALTH SOLUTIONS INC.
(Exact Name of Registrant as Specified in Its Charter)  
_______________________________
Delaware
001-15989
13-4022871
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
1400 Atwater Drive, Malvern, Pennsylvania
19355
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code (484) 216-0000
Not Applicable
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 




Item 5.07.    Submission of Matters to a Vote of Security Holders.
(a)    On May 22, 2013, the Company held its Annual Meeting of Stockholders.
(b)    Stockholders voted on the matters set forth below.
1.
The proposal to elect ten directors, representing all of the members of the Board of Directors of the Company, to serve until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified was approved based upon the following votes:
    
Nominee
Votes For Approval
Votes Against
Abstentions
Broker
Non-Votes
Roger H. Kimmel
95,895,951

370,123

14,226

7,193,513

Rajiv De Silva
96,101,516

165,325

13,459

7,193,513

John J. Delucca
96,148,354

118,462

13,484

7,193,513

Nancy J. Hutson, Ph.D.
96,131,692

136,165

12,443

7,193,513

Michael Hyatt
95,899,474

365,283

15,543

7,193,513

William P. Montague
96,142,582

122,033

15,685

7,193,513

David B. Nash, M.D., M.B.A.
96,156,536

107,589

16,175

7,193,513

Joseph C. Scodari
96,157,454

109,394

13,452

7,193,513

Jill D. Smith
96,081,659

186,197

12,444

7,193,513

William F. Spengler
96,151,804

112,920

15,576

7,193,513

2.
The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013 was approved based upon the following votes:
    
Votes for approval
102,033,363

Votes against
1,362,169

Abstentions
78,281

3.
The proposal to approve, by advisory vote, named executive officer compensation was approved based upon the following votes:
    
Votes for approval
87,484,051

Votes against
8,339,250

Abstentions
456,999

Broker non-votes
7,193,513

4.
Such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof:
None.
(c)    Not applicable.
(d)    Not applicable.




Item 9.01.    Financial Statements and Exhibits.
(a)    Financial Statements of Business Acquired.
Not applicable.
(b)    Pro Forma Financial Information.
Not applicable.
(c)    Shell Company Transactions.
Not applicable.
(d)    Exhibits.
None.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 
 
ENDO HEALTH SOLUTIONS INC.
(Registrant)
 
 
By:
/s/ CAROLINE B. MANOGUE
Name:
Caroline B. Manogue
Title:
Executive Vice President, Chief Legal Officer & Secretary
Dated: May 23, 2013